分子内力
化学
立体化学
活动站点
卤素
效力
基因亚型
晶体结构
结晶学
酶
生物化学
基因
体外
有机化学
烷基
作者
Roberta Tesch,Christian F. W. Becker,Matthias Müller,Michael E. Beck,Lena Quambusch,Matthäus Getlik,Jonas Lategahn,Niklas Uhlenbrock,Fanny Nascimento Costa,Marcelo D. Polêto,Pedro de Sena Murteira Pinheiro,Daniel Alencar Rodrigues,Carlos Maurício R. Sant’Anna,Fábio Furlan Ferreira,Hugo Verli,Carlos Alberto Manssour Fraga,Daniel Rauh
标识
DOI:10.1002/anie.201804917
摘要
Abstract PIK‐75 is a phosphoinositide‐3‐kinase (PI3K) α‐isoform‐selective inhibitor with high potency. Although published structure–activity relationship data show the importance of the NO2 and the Br substituents in PIK‐75, none of the published studies could correctly determine the underlying reason for their importance. In this publication, we report the first X‐ray crystal structure of PIK‐75 in complex with the kinase GSK‐3β. The structure shows an unusual U‐shaped conformation of PIK‐75 within the active site of GSK‐3β that is likely stabilized by an atypical intramolecular Br⋅⋅⋅NO2 halogen bond. NMR and MD simulations show that this conformation presumably also exists in solution and leads to a binding‐competent preorganization of the PIK‐75 molecule, thus explaining its high potency. We therefore suggest that the site‐specific incorporation of halogen bonds could be generally used to design conformationally restricted bioactive substances with increased potencies.
科研通智能强力驱动
Strongly Powered by AbleSci AI